Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BMY (bristol myers squibb) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (26)	3/13/1998 9:06:00 AM
From: wallstreeter	Read Replies (1) \| Respond to of 194

OMEGAMED Hello everyone i started the OMEGAMED thread here on silicon investor and from the info packet i have recieved it says that BMY might be interested in acquiring omegamed's new infusion pump for propietary labeling once omega gets into the production stage of the pump. This is a pump that works on the newest vaccuum technology and really beats baxters and blocks pumps which work on a ballon system. Hopefully this would help both BMY and OMEGA'S products once OMEGA gets FDA approval which could be in june or june.

To: Henry Niman who wrote (26)	5/9/1998 2:59:00 PM
From: Hank	Respond to of 194

Henry, FWIW, I think this idea of BMY and SBH hooking up is a load of nonsense. BMY is spending a large amount of money to double their research facilities in NJ and CT. Why would they take on a merger as well? They have stated point blank that they are not interested in growing through major mergers at this time but through internal growth. They have the fastest growth rate in terms of sales of any major drug company. A major merger for them at this juncture would be a ball and chain IMHO. Hank